# 119-s-3469: BIOSECURE Act of 2025 119-s-3469, BIOSECURE Act of 2025, is a 119th Congress bill sponsored by Sen. Peters, Gary C. [D-MI] (D-MI); status introduced; PRIA reads it as touching household money (as of 2026-04-21). - Canonical: https://policyrisk.com/legislation/119-s-3469 - As of: 2026-04-21 - Plain-text twin of the page above; the HTML and this file carry the same facts. ## Facts - Bill: 119-s-3469 - Congress: 119 - Title: BIOSECURE Act of 2025 - Status: introduced - Introduced: 2025-12-11 - Sponsor: Sen. Peters, Gary C. [D-MI] (D-MI) - Cosponsors: 1 - Policy area: Health - Touches household money: yes - Last recorded action: 2026-04-21 ## Summary **Restricts federal contracting with identified "biotechnology companies of concern" by blocking agencies from buying certain biotech equipment or services and setting up a federal process to list, review, and waive those firms.** - Federal agencies would be barred from procuring or contracting for biotechnology equipment or services produced by listed companies and from using loan or grant funds to obtain those products. - Companies and their parents, subsidiaries, or successors could be placed on a DoD-informed list, get a designation notice, have 90 days to oppose, and face phased prohibitions that start 60 or 90 days after Federal Acquisition Regulation updates. - The Office of Management and Budget could grant case-by-case waivers with 30-day congressional notice, generally up to 365 days with one possible 180-day national-security extension; the bill also carves out exceptions for certain intelligence activities, overseas U.S. health care, public multiomic data, and public health emergency countermeasures. *The bill does not authorize additional funds to carry out its provisions.* ## Cosponsors (1) - Sen. Hagerty, Bill [R-TN] (R-TN), 2025-12-11T00:00:00.000Z ## Provisions PRIA read - Risk study and annual intelligence reports: benefit, medium. If enacted, the Director of National Intelligence would assess national-security risks from foreign-held U.S. human multiomic data and finish the study within 270 days. The DNI must send an unclassified report to Congress within 30 days after completing the assessment, with an optional classified a… - VA deemed compliant for Medicaid pricing: benefit, low. If enacted, certain drug manufacturers would be treated as meeting VA master agreement rules for Medicaid price calculations when the procurement ban prevents formal VA agreements. The VA Secretary must determine the manufacturer would have complied but for the ban. This could help keep Medicaid dr… - How the government names risky firms: cost, medium. If enacted, the Office of Management and Budget would publish a federal list of biotechnology companies of concern within one year. OMB would base the list in part on a DoD-provided list and coordinate with other agencies. Companies designated under the non-DoD criteria must get notice, have 90 day… - Ban on federal biotech purchases: cost, medium. If enacted, federal agencies would be barred from buying biotech equipment or services made by designated companies. The bill would define covered items broadly, including sequencers, parts, and the software needed to run them. It would also define which firms are "biotechnology companies of concer… - No new money for implementation: cost, low. If enacted, the bill would not authorize any new funds to carry out these rules. Agencies would have to use existing budgets, which could slow or limit how quickly parts of the program are put in place. - Agency waivers and procurement exceptions: mixed, low. If enacted, the bill would create narrow exceptions and waivers allowing some purchases despite the ban. Exceptions include authorized intelligence work, lawfully compiled public or commercial multiomic data, medical countermeasures during a declared public health emergency, and certain overseas he… ## Related bills - 119-s-5022: Cannabis Administration and Opportunity Act - 119-s-2975: PIPELINE Safety Act of 2025 - 119-s-1748: Kids Online Safety Act - 119-s-5283: Momnibus Act - 119-s-5025: Lindsey O. Graham Sanctioning Russia Act of 2026 - 119-s-1639: American Innovation and Jobs Act ## Sources - [119-s-3469 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/3469) ## Related - [119-s-5022: Cannabis Administration and Opportunity Act](https://policyrisk.com/legislation/119-s-5022) - [119-s-2975: PIPELINE Safety Act of 2025](https://policyrisk.com/legislation/119-s-2975) - [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748) - [119-s-5283: Momnibus Act](https://policyrisk.com/legislation/119-s-5283) - [119-s-5025: Lindsey O. Graham Sanctioning Russia Act of 2026](https://policyrisk.com/legislation/119-s-5025) - [119-s-1639: American Innovation and Jobs Act](https://policyrisk.com/legislation/119-s-1639) - [All bills in Congress](https://policyrisk.com/legislation) Source: PRIA, https://policyrisk.com/legislation/119-s-3469 (as of 2026-04-21).